A Study of the Cardiac Effects of ALXN1840 in Healthy Adults
Clinical trial NCT04560816 · COMPLETED
Trial details
- NCT number
- NCT04560816
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2021-03-24
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.